Twenty-five years of surveillance for familial and hereditary pancreatic ductal adenocarcinoma: Historical perspectives and introduction to the special issue
- PMID: 38844715
- PMCID: PMC11255030
- DOI: 10.1007/s10689-024-00404-0
Twenty-five years of surveillance for familial and hereditary pancreatic ductal adenocarcinoma: Historical perspectives and introduction to the special issue
Abstract
In the 1990s, as prevention became a central strategy in the battle against cancer and the molecular genetics revolution uncovered the genetic basis of numerous hereditary cancer syndromes, there were no options available for patients at increased risk of developing pancreatic cancer. When surveillance efforts for those at familial and hereditary risk of pancreatic cancer emerged in the late 1990s, it was uncertain if early detection was achievable.In this introduction to the special issue, we offer an overview of the history of surveillance for pancreatic cancer, including the first reports of familial pancreatic cancer in the medical literature, the initial results of surveillance in the United States and the initiation of surveillance programs for hereditary pancreatic cancer in the Netherlands.This special issue features a collection of 18 articles written by prominent experts in the field, focusing specifically on refining surveillance methodologies with the primary objective of improving care of high-risk individuals. Several reviews in this collection highlight improved survival rates associated with pancreas surveillance, underlying the potential of early detection and improved management in the continuing fight against pancreatic cancer.
Keywords: Early detection; Familial pancreatic cancer; Genetics; History; Pancreatic ductal adenocarcinoma; Surveillance.
© 2024. The Author(s).
Conflict of interest statement
Hans FA Vasen is Editor-in-Chief of Familial Cancer. Marcia I Canto: Royalties UpToDate (familial pancreatic cancer), Michael Goggins: no conflicts of interest.
Figures


Similar articles
-
Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals.Hematol Oncol Clin North Am. 2022 Oct;36(5):929-942. doi: 10.1016/j.hoc.2022.06.004. Hematol Oncol Clin North Am. 2022. PMID: 36265991 Review.
-
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.World J Gastroenterol. 2014 Aug 28;20(32):11182-98. doi: 10.3748/wjg.v20.i32.11182. World J Gastroenterol. 2014. PMID: 25170203 Free PMC article. Review.
-
Surveillance Outcome and Genetic Findings in Individuals at High Risk of Pancreatic Cancer.Clin Transl Gastroenterol. 2024 Feb 1;15(2):e00668. doi: 10.14309/ctg.0000000000000668. Clin Transl Gastroenterol. 2024. PMID: 38147532 Free PMC article.
-
Familial pancreatic cancer: Concept, management and issues.World J Gastroenterol. 2017 Feb 14;23(6):935-948. doi: 10.3748/wjg.v23.i6.935. World J Gastroenterol. 2017. PMID: 28246467 Free PMC article. Review.
-
Hereditary pancreatic cancer.Best Pract Res Clin Gastroenterol. 2022 Jun-Aug;58-59:101783. doi: 10.1016/j.bpg.2021.101783. Epub 2022 Jan 3. Best Pract Res Clin Gastroenterol. 2022. PMID: 35988957 Review.
References
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical